Yatsen reports strong growth in Q4 2025 with 20.1% revenue increase, driven by skincare brands and strategic R&D initiatives. Learn more about its financial outlook.

In its fourth quarter and full-year earnings call for 2025, Yatsen demonstrated a robust recovery in both revenue and profitability, reflecting a well-executed strategy amid a competitive landscape in the beauty industry. With total net revenues growing by 20.1% year-over-year in Q4 and a commendable 26.7% increase for the entire year, the company has managed to turn around its fortunes, particularly through its skincare brands.

Financial Performance

Yatsen's financial metrics for Q4 2025 showcased a solid performance:

• Total Net Revenue: RMB 1.38 billion, up from RMB 1.15 billion in Q4 2024.
• Revenue Growth: 20.1% year-over-year, significantly outpacing the industry average.
• Skincare Brands Revenue: Contributed 51.9% growth, indicating a growing consumer preference for skincare over color cosmetics.
• Net Income: Yatsen reported a net income of RMB 3 million for Q4, a significant recovery from a net loss of RMB 378.8 million in the same period last year.
• Gross Margin: Maintained at 77.7%, slightly down from 77.8% year-over-year, indicating stable cost management.

For the full year, the company reported:

• Total Net Revenue: RMB 4.3 billion, up from RMB 3.39 billion.
• Net Loss: Narrowed to RMB 92.4 million compared to RMB 710.2 million in 2024.
• Non-GAAP Net Income: Achieved a turnaround to RMB 8.4 million from a loss of RMB 128.2 million the previous year.

This financial performance underscores Yatsen's successful navigation through a challenging market characterized by intensified competition and changing consumer preferences.

Strategic Initiatives

Yatsen's growth is attributed to its strategic focus on several key initiatives:

1. Research and Development (R&D): The company has been investing heavily in R&D, leading to innovative product launches. For example, Galaniq's recent introduction of the VV Serum and the CO2 Revelation Cellulaire cream illustrates the company's commitment to R&D-driven innovation. These products have quickly become top sellers, demonstrating effective market penetration.
2. Brand Diversification: Yatsen maintains a diverse portfolio that ranges from mass to premium brands. This comprehensive approach allows them to tailor offerings to meet the needs of various consumer segments. The launch of Dr. Wu's PDR Serum is an example of this strategy, targeting consumers seeking clinical-grade results at home.
3. Operational Efficiency: The company is optimizing its product mix by focusing on higher-margin products and enhancing operational workflows. This strategic shift aims to improve profitability while sustaining growth momentum, as indicated by a decrease in operating loss margins from 24.3% to 4.3% for the year.

These initiatives not only reflect Yatsen's adaptability but also highlight its long-term commitment to building strong brand equity through innovation and operational excellence.

Future Outlook

Looking ahead, Yatsen's management provided an optimistic outlook for 2026. The company anticipates total net revenues for Q1 2026 to fall between RMB 958.6 million and RMB 1.08 billion, translating to a year-over-year increase of 15% to 30%. This guidance is based on current market conditions, which Yatsen believes will support continued growth.

Management emphasized that the skincare segment will remain a key driver of revenue, with plans to further enhance product offerings through ongoing R&D investment. The focus on improving net profit margins through efficient operations and higher-margin product prioritization will also be pivotal.

Furthermore, Yatsen's ability to leverage consumer insights and trends will be crucial in maintaining competitive advantage in the beauty market, particularly as competition intensifies during major shopping events such as the Double 11 festival.

Conclusion

In summary, Yatsen's fourth quarter and full-year earnings results reflect a significant turnaround in performance, driven by strategic initiatives focused on R&D, brand diversification, and operational efficiency. With a positive outlook for 2026, the company is well-positioned to capitalize on the growing demand in the beauty industry, particularly in the skincare segment. Investors can take heart in Yatsen's commitment to innovation and profitability as it navigates a competitive landscape, reaffirming its position as a key player in the beauty market.

As Yatsen continues to execute its strategy, it will be crucial to monitor its ability to sustain growth and improve margins in the coming quarters, ensuring it remains competitive in a rapidly evolving industry.